Nuwellis Inc (NUWE)

Currency in USD
3.890
-0.210(-5.12%)
Closed·
4.190+0.300(+7.71%)
·
Advertisement
Unusual Pre-Market activity
NUWE is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.8304.120
52 wk Range
2.5251,556.069
Key Statistics
Prev. Close
3.89
Open
4.09
Day's Range
3.83-4.12
52 wk Range
2.525-1,556.069
Volume
12.34K
Average Volume (3m)
818.3K
1-Year Change
-99.456%
Book Value / Share
24.29
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NUWE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Nuwellis Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Nuwellis Inc Earnings Call Summary for Q3/2026

  • Q3 revenue flat at $2.2M YoY, but 9-month sales rose 13% to $6.6M; gross margin expanded to 70% from 65%, operating loss improved 24% to $2.1M.
  • Console sales nearly doubled to 32 units in first 9 months vs 17 prior year; pediatric net sales up 20% in Q3 and 26% YTD, driving growth.
  • Operating expenses cut 13% YoY to $3.6M; company holds $8.3M cash, sufficient to fund operations through Q2 2027 per management guidance.
  • Filed 510(k) to expand Aquadex for patients as small as 5kg vs current 20kg minimum, potentially broadening pediatric market access if cleared.
  • Three product launches planned for Q1-H1 2027: Aquadex SmartView, Zorro-Flow pediatric system, and Pressure IQ; added AtriAmp via co-promotion deal.
Last Updated: 12/11/2026, 14:54
Read Full Transcript

Earnings

Latest Release
12/11/2026
EPS / Forecast
-5.82 / --
Revenue / Forecast
2.21M / 2.31M
EPS Revisions
Last 90 days

Compare NUWE to Peers and Sector

Metrics to compare
NUWE
Peers
Sector
Relationship
P/E Ratio
−0.1x−1.9x−0.2x
PEG Ratio
-−0.050.00
Price/Book
0.2x1.8x2.6x
Price / LTM Sales
0.2x2.4x2.7x
Upside (Analyst Target)
-156.6%69.6%
Fair Value Upside
Unlock−7.4%11.7%Unlock

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
2.53K0.62%11.33K
Other Institutional Investors
76.41K18.85%342.29K
Public Companies & Retail Investors
326.32K80.52%1.46M
Total
405.25K100.00%1.82M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Lind Global Fund III, LP5.29%21,45096
The Lind Partners, LLC5.29%21,45096

People Also Watch

1.990
BKYI
+2.58%
0.629
FRGT
-10.01%
4.2000
TGL
+15.70%
9.28
AIOK
+1.09%
0.4449
PLCEQ
+17.08%

FAQ

What Is the Nuwellis (NASDAQ: NUWE) Share Price Today?

The Nuwellis stock price today is 3.890 USD.

What Stock Exchange Does Nuwellis (NUWE) Trade On?

Nuwellis is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Nuwellis?

The stock symbol (also called a 'ticker') for Nuwellis is "NUWE."

What Is the Current Nuwellis Market Capitalisation?

As of today, Nuwellis (NASDAQ: NUWE) market cap is 1.580M USD.

What Is Nuwellis's (NUWE) Earnings Per Share (TTM)?

The Nuwellis EPS is currently -148.64 (Trailing Twelve Months).

Is NUWE a Buy or Sell From a Technical Analyst Perspective?

Based on today's Nuwellis moving averages and other technical indicators, the daily buy/sell signal for NUWE stock is Strong Sell.

How Many Times Has Nuwellis Stock Split?

Nuwellis has split 13 times. (See the NUWE stock split history page for full effective split date and price information.)

How Many Employees Does Nuwellis Have?

Nuwellis has 38 employees, based on their latest Companies House report.

What is the current trading status of Nuwellis (NASDAQ: NUWE)?

As of 19/11/2026, Nuwellis (NUWE) is trading at a share price of 3.890 USD, with a previous close of 3.890 USD. The stock has fluctuated within a day range of 3.830 USD to 4.120 USD, while its 52-week range spans from 2.525 USD to 1,556.069 USD.

What Is the NUWE Premarket Price?

NUWE's last pre-market stock price is 4.190 USD. The pre-market share volume is 250.000, and the stock has decreased by 0.300, or 7.710%.

What Is the NUWE After Hours Price?

NUWE's last after hours stock price is 4.000 USD, the stock has decreased by 0.110, or 2.830%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.